Our plain-English summary of Pulmonary histiocytosis X in a patient with epithelioid mesothelioma, by J. Morrison, S. Stamenkovic, W.S. Walker, et al (Histopathology, 2006).
You don't need the product names or old records. No fee unless we recover compensation for your family.
The study
- Authors: J. Morrison, S. Stamenkovic, W.S. Walker, W.A. Wallace
- Journal: Histopathology
- Published: 2006;49(3):320-1
- Type of article: Case report, Letter
- Cited by: 1 article, as counted by NIH iCite
- Read it: PubMed · Publisher
In plain English
This letter to the journal was a case report from the Royal Infirmary of Edinburgh, UK. The patient was a 49-year-old male smoker with a significant history of asbestos exposure who was referred with a persistent cough. The article did not describe the type of asbestos or how he was exposed. A biopsy of the parietal pleura (the lining of the chest wall) showed epithelioid mesothelioma. Staging tests found no metastasis, and he had a pleuropneumonectomy. Examination of the removed tissue confirmed epithelioid mesothelioma (pT2 N1 Mx). It also showed focal emphysema, especially in the upper lobe, and scarred nodules containing Langerhans cells, consistent with pulmonary histiocytosis X, a rare lung disease. The authors believed this was the first report of the two conditions together. They considered asbestos the likely cause of the mesothelioma and smoking the likely cause of the emphysema and histiocytosis X. They found no evidence in the literature that asbestos played a role in histiocytosis X, and concluded that the combination was probably an incidental association.
We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.
What the study did and found
- Design: case report (letter to the journal)
- Who was studied: one patient, a 49-year-old male smoker referred with a persistent cough, seen at the Departments of Thoracic Surgery and Pathology, Royal Infirmary of Edinburgh, UK; dates not given
- Exposure: a significant history of asbestos exposure (fiber type, job and dose not described), and smoking
- Main results:
- A thoracoscopic biopsy of the parietal pleura showed epithelioid mesothelioma.
- Staging investigations (bronchoscopy and mediastinoscopy) showed no metastasis, and the patient underwent pleuropneumonectomy.
- Examination of the resection specimen confirmed epithelioid mesothelioma, staged pT2 N1 Mx.
- The upper lobe of the lung showed focal emphysema.
- The lung tissue contained stellate nodular scars with Langerhans cells that stained for S100 and CD1a, consistent with pulmonary histiocytosis X (pulmonary eosinophilic granuloma).
- The authors believed this was the first report of a patient with coexisting pulmonary histiocytosis X and mesothelioma.
- The authors considered asbestos exposure the likely cause of the mesothelioma, and smoking the likely cause of the emphysema and pulmonary histiocytosis X.
- The authors' conclusion: The authors found no evidence in the literature that asbestos played a role in pulmonary histiocytosis X. They concluded that its occurrence with mesothelioma in this patient was probably an incidental association.
Topics
The National Library of Medicine indexes this study under subjects our site covers: Mesothelioma.
Medical terms in this study, explained in our Lexicon: Epithelioid, Mesothelioma.
Related studies
- Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema — M.D. Jankowich, S. Rounds (2010)
- Asbestos-induced and smoking-related disease: apportioning pulmonary function deficit by using thin-section CT — S.J. Copley, Y.C. Lee, et al. (2007)
- Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases — M.R. Wick, T. Loy, et al. (1990)
- Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma — M. Kuraoka, V.J. Amatya, et al. (2017)
- Epithelioid pleural mesothelioma concurrently associated with miliary pulmonary metastases and minimal change nephrotic syndrome - A hitherto undescribed case — Y. Tsukamoto, T. Otsuki, et al. (2015)
- Primary pulmonary epithelioid sarcoma: a case report — E. Mizutani, R. Morita, et al. (2021)
Browse more research in Histopathology, or return to medical research.
Cited on this site
How to cite it
Cite the study
J. Morrison, S. Stamenkovic, W.S. Walker, W.A. Wallace. Pulmonary histiocytosis X in a patient with epithelioid mesothelioma. Histopathology 2006;49(3):320-1. doi:10.1111/j.1365-2559.2006.02391.x. PMID: 16918985.
Cite our summary
“Pulmonary histiocytosis X in a patient with epithelioid mesothelioma.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/pulmonary-histiocytosis-x-in-a-patient-with-epithelioid-mesothelioma.
ACL Doc numbers and their short links never change. See how to cite the Library.
Talk with an asbestos lawyer
Start with what you remember, and we'll take it from there.
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.